| Literature DB >> 33436787 |
Giosafat Spitaleri1, Josep Lupón1,2,3, Mar Domingo1, Evelyn Santiago-Vacas1, Pau Codina1, Elisabet Zamora1,2,3, Germán Cediel1,2, Javier Santesmases1,2, Crisanto Diez-Quevedo1, Maria Isabel Troya1, Maria Boldo1, Salvador Altmir1, Nuria Alonso1, Beatriz González1, Julio Núñez3,4,5, Antoni Bayes-Genis6,7,8,9.
Abstract
To assess mortality trends at 1 and 3 years from 2001 to 2018 in a real-life cohort of HF outpatients from different etiologies with depressed and preserved LVEF. A total of 2368 consecutive patients with HF (mean age 66.4 ± 12.9 years, 71% men, 15.4% with preserved LVEF) admitted to a HF clinic from August 2001 to September 2018 were included in the study. Patients were divided into five quintiles (Q) according to the period of admission. Trends for all-cause and cardiovascular mortality from Q1 to Q5 were assessed by linear regression. Patients with LVEF < 50% had a progressive decrease in the rates of all-cause and cardiovascular death at 1 year (12.1% in Q1 to 6.5% in Q5, p = 0.003; and 8.4% in Q1 to 3.8% in Q5, p = 0.007, respectively) and 3 years (30.5% in Q1 to 17.0% in Q5, p = 0.003; and 23.9% in Q1 to 9.8% in Q5, p = 0.003, respectively). These trends remained significant after adjusting for clinical characteristics and risk. No significant trend in mortality was observed in patients with LVEF ≥ 50%. In a cohort of real-life ambulatory patients with HF, mortality progressively declined in patients with LVEF < 50%, but the same trend was not observed in patients with preserved LVEF.Entities:
Year: 2021 PMID: 33436787 PMCID: PMC7804393 DOI: 10.1038/s41598-020-79926-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379